Institutional members access full text with Ovid®

Share this article on:

Genetic Testing in Ovarian Cancer: Getting Better, and Maybe Not Just for Disease Susceptibility Anymore

Berchuck, Andrew MD

doi: 10.1097/AOG.0b013e3182602599

See related article on page 235.

Dr. Berchuck is Director of the Gynecologic Cancer Program in the Duke Cancer Institute and Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at Duke University Medical Center, Durham, North Carolina; e-mail:

Financial Disclosure The author did not report any potential conflicts of interest.

© 2012 The American College of Obstetricians and Gynecologists